# Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients

> **NCT01640184** · NA · COMPLETED · sponsor: **Dongliang Zhang, MD** · enrollment: 79 (actual)

## Conditions studied

- Hyperparathyroidism
- Disorders of Parathyroid Gland

## Interventions

- **PROCEDURE:** Parathyroidectomy
- **DRUG:** Active vitamin D
- **PROCEDURE:** Ultrasonic ablation

## Key facts

- **NCT ID:** NCT01640184
- **Lead sponsor:** Dongliang Zhang, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2016-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640184, "Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01640184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*